Nanobodies are antigen-binding entities derived from the heavy chain-only antibodies that retain full antigen specificity at a very small size (13 kDa). The Xu lab focuses on Nanobodies that can penetrate tissues and recognize epitopes that are often inaccessible to conventional antibodies. At Xu Lab, establish efficient nanobody development platforms and use these platforms to produce novel biological molecules across multiple therapeutic areas, including infectious diseases and immuno-oncology.
Ph.D. position is available to study Nanobody platforms development using transgenic mouse models, phage display, yeast display, mRNA display, directed evolution, and deep sequencing.
Eligible candidates can write to Jianliang Xu, Ph.D. (jxu40@gsu.edu) for more information, or apply here
For more global phage-related research and job opportunities, click here
